Published in Clin Pharmacol Ther on September 01, 1974
The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol. Br J Clin Pharmacol (1976) 1.12
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol. Br J Clin Pharmacol (1980) 0.80
Combination of clonidine and sotalol in hypertension. Br Med J (1976) 0.75
Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet (1989) 3.33
Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology (1998) 2.44
Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet (1992) 2.38
Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections. Ann Clin Res (1978) 2.07
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent. Ann Clin Res (1969) 1.71
Hyaluronan in human malignancies. Exp Cell Res (2010) 1.63
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health (2001) 1.57
Diagnostic features of acute myocardial infarction--changes over time from 1983 to 1990: results from the FINMONICA AMI Register Study. J Intern Med (1995) 1.49
The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA (1994) 1.48
Gender differences in recurrent coronary events; the FINMONICA MI register. Eur Heart J (2001) 1.41
Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet (1991) 1.39
21 year trends in incidence of myocardial infarction and mortality from coronary disease in middle-age. Eur Heart J (1996) 1.39
Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation (1993) 1.37
The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol (1997) 1.36
Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol (Copenh) (1976) 1.27
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation (1996) 1.24
Bacterial pneumonia can increase serum concentration of clozapine. Eur J Clin Pharmacol (2002) 1.22
Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J (1992) 1.20
Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy (1976) 1.20
Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther (2000) 1.16
Long-term reduction in sudden deaths after a multifactorial intervention programme in patients with myocardial infarction: 10-year results of a controlled investigation. Eur Heart J (1989) 1.10
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09
Pneumococcal conjugate vaccines. Pediatr Infect Dis J (1999) 1.05
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03
Trends in coronary events in Finland during 1983-1997. The FINAMI study. Eur Heart J (2003) 1.02
The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983-1992. Finnish multinational MONItoring of trends and determinants in CArdiovascular disease. J Clin Epidemiol (1999) 0.99
Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am J Epidemiol (1992) 0.96
Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther (1992) 0.95
Secondary prevention of urinary tract infections. The role of trimethoprim alone. Ann Clin Res (1983) 0.94
Naproxen concentrations in serum, synovial fluid, and synovium. Scand J Rheumatol (1977) 0.94
Atipamezole increases medetomidine clearance in the dog: an agonist-antagonist interaction. J Vet Pharmacol Ther (1995) 0.92
Thrombolytic treatment for thrombotic complication of valve prosthesis after tricuspid valve replacement. A case report. Scand J Thorac Cardiovasc Surg (1977) 0.92
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Clin Pharmacol Ther (1998) 0.91
Pharmacokinetics of naproxen in subjects with normal and impaired renal function. Eur J Clin Pharmacol (1980) 0.91
Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev (2000) 0.90
Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Pediatr Infect Dis J (1993) 0.90
Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia (2005) 0.90
Electrocardiographic and vectorcardiographic signs of left and right ventricular hypertrophy in endurance athletes. J Sports Med Phys Fitness (1966) 0.89
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol (2007) 0.89
Penetration of naproxen and salicylate into inflammatory exudates in the rat. Ann Rheum Dis (1977) 0.88
Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol (1990) 0.87
Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study. Ann Clin Res (1973) 0.87
Picogram level determination of medetomidine in dog serum by capillary gas chromatography with negative ion chemical ionization mass spectrometry. J Chromatogr (1989) 0.87
Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun (2000) 0.86
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity. Clin Pharmacol Ther (1979) 0.86
Seral, uterine and fetal salicylate concentrations after oral administration. Eur J Obstet Gynecol Reprod Biol (1981) 0.86
Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine (2000) 0.85
Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity. Acta Obstet Gynecol Scand (1982) 0.84
Permanent endocardial pacing. An analysis of 90 patients. Acta Med Scand Suppl (1976) 0.84
Oral contraceptive containing natural estradiol for premenopausal women. Maturitas (1995) 0.84
Metoprolol, nifedipine, and the combination in stable effort angina pectoris. Am J Cardiol (1986) 0.84
Determination of erythromycin base and 2'-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection. J Chromatogr (1990) 0.83
IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Bone Marrow Transplant (1999) 0.83
Lack of adverse interactions between concomitantly administered selegiline and citalopram. Clin Neuropharmacol (1997) 0.83
The effect of antimicrobial growth promoter withdrawal on the health of weaned pigs in Finland. Prev Vet Med (2004) 0.83
Effect of food, food constituents and fluid volume on the bioavailability of sotalol. Acta Pharmacol Toxicol (Copenh) (1979) 0.83
Reduction of dosing frequency of carbamazepine with a slow-release preparation. Epilepsy Res (1989) 0.82
Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids. Br J Clin Pharmacol (1999) 0.81
Pharmacokinetics and metabolism of selegiline. Acta Neurol Scand Suppl (1989) 0.80
Comparative bioavailability and pharmacokinetics of sotalol administered alone and in combination with hydrochlorothiazide. J Clin Pharmacol (1979) 0.80
Neither hippurate-negative Brachyspira pilosicoli nor Brachyspira pilosicoli type strain caused diarrhoea in early-weaned pigs by experimental infection. Acta Vet Scand (2005) 0.80
Leishmaniosis mimicking oral neoplasm in a dog: an unusual manifestation of an unusual disease in Finland. Acta Vet Scand (2000) 0.80
Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes. Pharmacol Toxicol (2000) 0.80
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol. Br J Clin Pharmacol (1980) 0.80
Clinical findings and return to work after heart valve replacement. Scand J Rehabil Med (1984) 0.79
Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice. Cancer Gene Ther (2010) 0.79
A new triphenylethylene compound, Fc-1157a. I. Hormonal effects. Cancer Chemother Pharmacol (1986) 0.79
Propranolol and sotalol metabolism after a drinking party. Clin Pharmacol Ther (1981) 0.78
Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone. Scand J Infect Dis (1982) 0.78
Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model. Lupus (2001) 0.78
Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation. Epilepsy Res (1990) 0.78
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole. Eur J Clin Pharmacol (2001) 0.78
Long-term prognosis after coronary artery bypass surgery. Int J Cardiol (2007) 0.78
Usefulness of internet in adolescent mental health outpatient care. J Psychiatr Ment Health Nurs (2010) 0.78
Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland. Rev Infect Dis (1982) 0.78
Comparative bioavailability of two commercial preparations of carbamazepine tablets. Eur J Clin Pharmacol (1979) 0.78
Pulse-conducted triangular exercise-ECG test. A feed-back system regulating work during exercise. Acta Med Scand Suppl (1972) 0.78
Types of fluid disorder in children with bacterial meningitis. Acta Paediatr Scand (1991) 0.78
Fluorometric determination of naproxen in serum. J Pharm Sci (1977) 0.78
Oxygen transport and tissue oxygenation under moderate and extreme hemodilution during coronary bypass surgery. Ann Clin Res (1981) 0.78
Experiences with the Björk-Shiley tilting disc valve in aortic and mitral valve surgery. Ann Chir Gynaecol (1976) 0.78
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine. Cancer Chemother Pharmacol (2000) 0.77
Multiple-dose pharmacokinetics of selegiline and desmethylselegiline suggest saturable tissue binding. Clin Neuropharmacol (2000) 0.77
Canine distemper of vaccine origin in European mink, Mustela lutreola--a case report. Vet Microbiol (2003) 0.77
Heavy metals in tissue samples of Finnish moose, Alces alces. Bull Environ Contam Toxicol (2005) 0.77
Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets. Acta Med Scand (1974) 0.77